Trial · NCT00566345
Results by group31
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 31
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Subjects Developing Influenza Infection, as Confirmed by Viral Culture and Typing of Naso-pharyngeal Specimens | Influenza Vaccine | 35 | Participants | ||
| Number of Subjects Developing Influenza Infection, as Confirmed by Viral Culture and Typing of Naso-pharyngeal Specimens | Placebo | 62 | Participants | ||
| The Consistency of Immune Response Produced by 3 Different Lots of VCIV Based on HIA Titer Values | Influenza Vaccine Lot 2 vs Lot 1 | Strain A/H1N1 | 1.22 | 95% Confidence Interval 1.07 to 1.39 | Geometric Mean Titers |
| The Consistency of Immune Response Produced by 3 Different Lots of VCIV Based on HIA Titer Values | Influenza Vaccine Lot 3 vs Lot 1 | Strain A/H1N1 | 1.10 | 95% Confidence Interval 0.96 to 1.25 | Geometric Mean Titers |
| The Consistency of Immune Response Produced by 3 Different Lots of VCIV Based on HIA Titer Values | Influenza Vaccine Lot 3 vs Lot 2 | Strain A/H1N1 | 0.90 | 95% Confidence Interval 0.79 to 1.02 | Geometric Mean Titers |
| The Consistency of Immune Response Produced by 3 Different Lots of VCIV Based on HIA Titer Values | Influenza Vaccine Lot 2 vs Lot 1 | Strain A/H3N2 | 0.94 | 95% Confidence Interval 0.83 to 1.07 | Geometric Mean Titers |
| The Consistency of Immune Response Produced by 3 Different Lots of VCIV Based on HIA Titer Values | Influenza Vaccine Lot 3 vs Lot 1 | Strain A/H3N2 | 0.99 | 95% Confidence Interval 0.87 to 1.13 | Geometric Mean Titers |
| The Consistency of Immune Response Produced by 3 Different Lots of VCIV Based on HIA Titer Values | Influenza Vaccine Lot 3 vs Lot 2 | Strain A/H3N2 | 1.05 | 95% Confidence Interval 0.93 to 1.20 | Geometric Mean Titers |
| The Consistency of Immune Response Produced by 3 Different Lots of VCIV Based on HIA Titer Values | Influenza Vaccine Lot 2 vs Lot 1 | Strain B | 0.88 | 95% Confidence Interval 0.78 to 0.99 | Geometric Mean Titers |
| The Consistency of Immune Response Produced by 3 Different Lots of VCIV Based on HIA Titer Values | Influenza Vaccine Lot 3 vs Lot 1 | Strain B | 0.91 | 95% Confidence Interval 0.81 to 1.02 | Geometric Mean Titers |
| The Consistency of Immune Response Produced by 3 Different Lots of VCIV Based on HIA Titer Values | Influenza Vaccine Lot 3 vs Lot 2 | Strain B | 1.04 | 95% Confidence Interval 0.92 to 1.17 | Geometric Mean Titers |
| Frequency and Severity of Occurrence of Any Injection Site Reactions and Systemic Reactions/Adverse Events Related to Vaccination | Influenza Vaccine | Non-Serious Local Reactions / No Reactions | 868 | Participants | |
| Frequency and Severity of Occurrence of Any Injection Site Reactions and Systemic Reactions/Adverse Events Related to Vaccination | Placebo | Non-Serious Local Reactions / No Reactions | 1586 | Participants | |
| Frequency and Severity of Occurrence of Any Injection Site Reactions and Systemic Reactions/Adverse Events Related to Vaccination | Influenza Vaccine | Non-Serious Local Reactions / Mild | 834 | Participants | |
| Frequency and Severity of Occurrence of Any Injection Site Reactions and Systemic Reactions/Adverse Events Related to Vaccination | Placebo | Non-Serious Local Reactions / Mild | 237 | Participants | |
| Frequency and Severity of Occurrence of Any Injection Site Reactions and Systemic Reactions/Adverse Events Related to Vaccination | Influenza Vaccine | Non-Serious Local Reactions / Moderate | 99 | Participants | |
| Frequency and Severity of Occurrence of Any Injection Site Reactions and Systemic Reactions/Adverse Events Related to Vaccination | Placebo | Non-Serious Local Reactions / Moderate | 7 | Participants | |
| Frequency and Severity of Occurrence of Any Injection Site Reactions and Systemic Reactions/Adverse Events Related to Vaccination | Influenza Vaccine | Non-Serious Local Reactions / Severe | 5 | Participants | |
| Frequency and Severity of Occurrence of Any Injection Site Reactions and Systemic Reactions/Adverse Events Related to Vaccination | Placebo | Non-Serious Local Reactions / Severe | 0 | Participants | |
| Frequency and Severity of Occurrence of Any Injection Site Reactions and Systemic Reactions/Adverse Events Related to Vaccination | Influenza Vaccine | Non-Serious Local Reactions / Unknown | 23 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00566345/results